Key Points AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments. Pfizer is leaning on heavy investment in oncology and strategic acquisitions to rebuild its growth profile for the future. Which pharmaceutical giant is the better addition to your portfolio today? 10 stocks we like better than AbbVie › Deciding between two pharmaceutical giants requires a close look at pipeline growth and patent longevity. For investors in 2026, comparing AbbVie (NYSE:ABBV) and Pfizer Inc (NYSE:PFE) reveals two very different paths to potential long-term returns.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。